Cargando…

Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS

Anamorelin, developed for the treatment of cancer cachexia, is an orally active medication that improves appetite and food intake, thereby increasing body mass and physical functioning. It is classified as a growth hormone secretagogue and strictly monitored by the World Anti-Doping Agency (WADA), o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gameli, Prince Sellase, Taoussi, Omayema, Basile, Giuseppe, Carlier, Jeremy, Busardò, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456928/
https://www.ncbi.nlm.nih.gov/pubmed/37623892
http://dx.doi.org/10.3390/metabo13080949